Bedell Frazier Investment Counselling’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-31,318
| Closed | -$6.07M | – | 109 |
|
|
2024
Q3 | $6.07M | Buy |
31,318
+17,628
| +129% | +$3.42M | 1.45% | 23 |
|
|
2024
Q2 | $3.17M | Buy |
13,690
+593
| +5% | +$137K | 0.77% | 41 |
|
|
2024
Q1 | $2.82M | Buy |
+13,097
| New | +$2.82M | 0.71% | 42 |
|
|
2018
Q4 | – | Sell |
-25,510
| Closed | -$9.01M | – | 48 |
|
|
2018
Q3 | $9.01M | Buy |
25,510
+128
| +0.5% | +$45.2K | 2.49% | 13 |
|
|
2018
Q2 | $7.37M | Sell |
25,382
-475
| -2% | -$138K | 2.16% | 25 |
|
|
2018
Q1 | $7.08M | Sell |
25,857
-60
| -0.2% | -$16.4K | 2.5% | 22 |
|
|
2017
Q4 | $8.26M | Buy |
25,917
+363
| +1% | +$116K | 3.07% | 16 |
|
|
2017
Q3 | $8M | Sell |
25,554
-27,960
| -52% | -$8.75M | 3.69% | 10 |
|
|
2017
Q2 | $14.5M | Buy |
53,514
+27,307
| +104% | +$7.41M | 5.3% | 3 |
|
|
2017
Q1 | $7.17M | Buy |
26,207
+1,762
| +7% | +$482K | 2.72% | 14 |
|
|
2016
Q4 | $6.93M | Buy |
24,445
+975
| +4% | +$276K | 2.73% | 13 |
|
|
2016
Q3 | $7.35M | Buy |
23,470
+1,779
| +8% | +$557K | 3.04% | 11 |
|
|
2016
Q2 | $5.2M | Buy |
21,691
+7,546
| +53% | +$1.81M | 2.57% | 19 |
|
|
2016
Q1 | $3.68M | Buy |
14,145
+1,166
| +9% | +$304K | 1.9% | 25 |
|
|
2015
Q4 | $3.98M | Buy |
+12,979
| New | +$3.98M | 1.97% | 23 |
|
|
2015
Q3 | – | Sell |
-15,199
| Closed | -$6.14M | – | 53 |
|
|
2015
Q2 | $6.14M | Buy |
15,199
+5,636
| +59% | +$2.28M | 2.44% | 14 |
|
|
2015
Q1 | $4.04M | Sell |
9,563
-6,952
| -42% | -$2.94M | 1.68% | 27 |
|
|
2014
Q4 | $5.61M | Buy |
+16,515
| New | +$5.61M | 2.75% | 10 |
|